Open Monoclonal Technology, Inc. Grants Unlimited Omnirat, Omnimouse And Omniflic Access To Another Global Pharmaceutical Company
1/7/2014 10:10:28 AM
PALO ALTO, Calif.--(BUSINESS WIRE)--(OMT) today announced granting unlimited OmniRat®, OmniMouse® and OmniFlic™ access to a global leader in generics and novel pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.
comments powered by